Immunomodulation as therapy for fungal infection: Are we closer?
10.3389/fmicb.2018.01612
Saved in:
Main Authors: | , , , , |
---|---|
Other Authors: | |
Format: | Review |
Published: |
Frontiers Media S.A.
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/174534 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-174534 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-1745342024-04-24T05:54:31Z Immunomodulation as therapy for fungal infection: Are we closer? Sam, Q.H. Yew, W.S. Seneviratne, C.J. Chang, M.W. Chai, L.Y.A. BIOCHEMISTRY DENTISTRY MEDICINE auranofin colony stimulating factor 1 cytokine receptor agonist deferasirox ebselen efungumab gamma interferon granulocyte colony stimulating factor granulocyte macrophage colony stimulating factor interleukin 12p40 interleukin 6 molgramostim probiotic agent recombinant gamma interferon recombinant granulocyte macrophage colony stimulating factor retinol sargramostim suppressor of cytokine signaling 3 tamoxifen toll like receptor 9 toll like receptor agonist tumor necrosis factor vitamin D adoptive T cell therapy antifungal therapy cell therapy chimeric antigen receptor natural killer cell immunotherapy chimeric antigen receptor T-cell immunotherapy clinical trial (topic) cryptococcal meningitis cryptococcosis Cryptococcus neoformans drug repositioning granulocyte transfusion human immunomodulation microbiome nonhuman phase 1 clinical trial (topic) phase 2 clinical trial (topic) Review systemic mycosis T lymphocyte 10.3389/fmicb.2018.01612 Frontiers in Microbiology 9 JUL 1612 2020-09-07T05:05:10Z 2020-09-07T05:05:10Z 2018 Review Sam, Q.H., Yew, W.S., Seneviratne, C.J., Chang, M.W., Chai, L.Y.A. (2018). Immunomodulation as therapy for fungal infection: Are we closer?. Frontiers in Microbiology 9 (JUL) : 1612. ScholarBank@NUS Repository. https://doi.org/10.3389/fmicb.2018.01612 1664302X https://scholarbank.nus.edu.sg/handle/10635/174534 Frontiers Media S.A. Unpaywall 20200831 |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
auranofin colony stimulating factor 1 cytokine receptor agonist deferasirox ebselen efungumab gamma interferon granulocyte colony stimulating factor granulocyte macrophage colony stimulating factor interleukin 12p40 interleukin 6 molgramostim probiotic agent recombinant gamma interferon recombinant granulocyte macrophage colony stimulating factor retinol sargramostim suppressor of cytokine signaling 3 tamoxifen toll like receptor 9 toll like receptor agonist tumor necrosis factor vitamin D adoptive T cell therapy antifungal therapy cell therapy chimeric antigen receptor natural killer cell immunotherapy chimeric antigen receptor T-cell immunotherapy clinical trial (topic) cryptococcal meningitis cryptococcosis Cryptococcus neoformans drug repositioning granulocyte transfusion human immunomodulation microbiome nonhuman phase 1 clinical trial (topic) phase 2 clinical trial (topic) Review systemic mycosis T lymphocyte |
spellingShingle |
auranofin colony stimulating factor 1 cytokine receptor agonist deferasirox ebselen efungumab gamma interferon granulocyte colony stimulating factor granulocyte macrophage colony stimulating factor interleukin 12p40 interleukin 6 molgramostim probiotic agent recombinant gamma interferon recombinant granulocyte macrophage colony stimulating factor retinol sargramostim suppressor of cytokine signaling 3 tamoxifen toll like receptor 9 toll like receptor agonist tumor necrosis factor vitamin D adoptive T cell therapy antifungal therapy cell therapy chimeric antigen receptor natural killer cell immunotherapy chimeric antigen receptor T-cell immunotherapy clinical trial (topic) cryptococcal meningitis cryptococcosis Cryptococcus neoformans drug repositioning granulocyte transfusion human immunomodulation microbiome nonhuman phase 1 clinical trial (topic) phase 2 clinical trial (topic) Review systemic mycosis T lymphocyte Sam, Q.H. Yew, W.S. Seneviratne, C.J. Chang, M.W. Chai, L.Y.A. Immunomodulation as therapy for fungal infection: Are we closer? |
description |
10.3389/fmicb.2018.01612 |
author2 |
BIOCHEMISTRY |
author_facet |
BIOCHEMISTRY Sam, Q.H. Yew, W.S. Seneviratne, C.J. Chang, M.W. Chai, L.Y.A. |
format |
Review |
author |
Sam, Q.H. Yew, W.S. Seneviratne, C.J. Chang, M.W. Chai, L.Y.A. |
author_sort |
Sam, Q.H. |
title |
Immunomodulation as therapy for fungal infection: Are we closer? |
title_short |
Immunomodulation as therapy for fungal infection: Are we closer? |
title_full |
Immunomodulation as therapy for fungal infection: Are we closer? |
title_fullStr |
Immunomodulation as therapy for fungal infection: Are we closer? |
title_full_unstemmed |
Immunomodulation as therapy for fungal infection: Are we closer? |
title_sort |
immunomodulation as therapy for fungal infection: are we closer? |
publisher |
Frontiers Media S.A. |
publishDate |
2020 |
url |
https://scholarbank.nus.edu.sg/handle/10635/174534 |
_version_ |
1800914252302647296 |